Ophthalmology Times: January 2020
It is imperative for physicians to ensure that patients are receiving the correct medications that they prescribe, and not a generic brand that may not meet the objectives.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA update: Outlook Therapeutics receives CRL for resubmitted ONS-5010 BLA
2
Inside the clinic: Surgeon shares real-world experience
3
FDA approvals in 2025: What changed and why it matters for ophthalmologists
4
PRIMAvera study: Central vision improvement with subretinal implant
5